Ocaratuzumab (Anti-CD20)
Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). MW: 145.38 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2969 |
| Sku # | A2969-1mg*25 |
| Pricing | 1mg*25, $2970.00 |